SIRUM (organization)

Last updated
SIRUM
Founded2009
FounderAdam Kircher, George Wang, Kiah Williams
TypeNon-governmental organization
Location
Area served
United States
Website sirum.org

SIRUM (Supporting Initiatives to Redistribute Unused Medicine) is a non-profit social enterprise started by Stanford University students to decrease the amount of medicine going to waste in the U.S. by redistributing unused, unexpired drugs to safety-net clinics. Using an innovative technology platform, SIRUM saves lives, time, and money by allowing health facilities, manufacturers, wholesalers, and pharmacies to easily donate unused medicine rather than destroy it.

Contents

Opportunity

An estimated $5 billion worth of usable medicine goes to waste each year in the United States [1] —yet 50 million Americans report not being able to afford taking their medications as prescribed. [2] Americans’ medication non-adherence results in an estimated 125,000 annual deaths and costs up to $289 billion annually. [3] The act of wasting that $5 billion of usable medicine each year also has consequences for Americans, polluting air and water supplies, and resulting in the duplicative purchasing and manufacturing of drugs to meet patient needs—which could otherwise be met by drawing on that $5 billion medication surplus.

Much of the surplus unused medicine wasted each year resides with healthcare companies and organizations, such as with long-term care facilities, pharmaceutical manufacturers, wholesalers, and pharmacies. Because these surplus medications remain in institutional settings throughout their life cycles, their integrity is carefully maintained by trained healthcare professionals. Patients who cannot afford to purchase the prescriptions they need could greatly benefit from having access to these safe, unexpired, and unopened medications that otherwise go to waste.

Forty states around the country have recently recognized this opportunity and passed so-called “Good Samaritan” laws providing legal protection and regulatory guidelines for the creation of medicine redistribution programs. [4]

Method of operation

SIRUM leverages technology to connect surpluses of unused medicine with safety-net clinics whose low-income patients cannot afford their medicine. Through SIRUM’s first-of-its-kind online platform, donor organizations can upload inventories of their unused medications while safety-net clinics upload their patients’ medication needs. SIRUM’s system then creates automatic matches between donating and recipient parties, and facilitates the speedy and direct shipment of medicine from facility to clinic. SIRUM’s online platform handles record-keeping, shipping, and other logistics. [5] Throughout each step of the process SIRUM aims to make medicine donation an easier, more enticing option than medicine destruction.

Results

As of mid-2014, SIRUM has medicine redistribution networks running in California and Colorado, with over 200 partners participating in total. The organization has facilitated the redistribution of 1 million pills, which amounts to about $3 million worth of drugs saved and 20,000 patients helped. [6] That also represents about two tons of medicine diverted away from our waste streams—and thousands of tons more waste avoided by forgoing the production of the 1 million pills these safety-net clinics would have otherwise had to purchase anew.

Legislation

SIRUM is possible because of two recent legal advancements. One is the enactment of Good Samaritan laws that have passed in 40 states. [7] These laws make it easier for certain types of donors to redistribute unused medicine without liability.

The second legal advancement is a Food and Drug Administration mandate that requires all manufactured medicine to be labeled with the National Drug Code, a consistent coding system that identifies medicine by type, strength, and amount. [8] SIRUM uses these standardized codes to match clinic requests with donor excess. The online system allows for medicine to be entered and requested using the trade name, active ingredient, NDC labeler code, NDC product code, or manufacturer. With all information contained within its database, SIRUM is able to match the needs of its member clinics.

History

Adam Kircher first had the idea for SIRUM in 2005. His experience with relief efforts in post-tsunami Batam, Indonesia alerted him to difficulties in redistributing supplies, including medicine. Adam was inspired to use the internet to create a trusted community for redistributing medicine, and he assembled a group of Stanford students to help achieve his aims. In 2009, SIRUM became incorporated and launched its pilot program in the San Francisco Bay Area. Since then, SIRUM has made its online platform increasingly robust and built out its donation network to include 200 partners across California and Colorado. Its early funders included the California HealthCare Foundation, the Robert Wood Johnson Foundation, and the Draper Richards Kaplan Foundation.

Related Research Articles

<span class="mw-page-title-main">Medication</span> Substance used to diagnose, cure, treat, or prevent disease

A medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

The Pharmaceutical Benefits Scheme (PBS) is a program of the Australian Government that subsidises prescription medication for Australian citizens and permanent residents, as well as international visitors covered by a reciprocal health care agreement. The PBS is separate to the Medicare Benefits Schedule, a list of health care services that can be claimed under Medicare, Australia's universal health care insurance scheme.

<span class="mw-page-title-main">Free clinic</span> Non-profit health care clinics in the US

A free clinic or walk in clinic is a health care facility in the United States offering services to economically disadvantaged individuals for free or at a nominal cost. The need for such a clinic arises in societies where there is no universal healthcare, and therefore a social safety net has arisen in its place. Core staff members may hold full-time paid positions, however, most of the staff a patient will encounter are volunteers drawn from the local medical community.

<span class="mw-page-title-main">Medicare Part D</span> United States prescription drug benefit for the elderly and disabled

Medicare Part D, also called the Medicare prescription drug benefit, is an optional United States federal-government program to help Medicare beneficiaries pay for self-administered prescription drugs. Part D was enacted as part of the Medicare Modernization Act of 2003 and went into effect on January 1, 2006. Under the program, drug benefits are provided by private insurance plans that receive premiums from both enrollees and the government. Part D plans typically pay most of the cost for prescriptions filled by their enrollees. However, plans are later reimbursed for much of this cost through rebates paid by manufacturers and pharmacies.

An online pharmacy, internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and sends orders to customers through mail, shipping companies, or online pharmacy web portal.

Direct-to-consumer advertising (DTCA) refers to the marketing and advertising of pharmaceutical products directly to consumers as patients, as opposed to specifically targeting health professionals. The term is synonymous primarily with the advertising of prescription medicines via mass media platforms—most commonly on television and in magazines, but also via online platforms.

<span class="mw-page-title-main">First Databank</span>

First Databank (FDB) is a major provider of drug and medical device databases that help inform healthcare professionals to make decisions. FDB partners with information system developers to deliver useful medication- and medical device-related information to clinicians, business associates, and patients. FDB is part of Hearst and the Hearst Health network.

Medication costs, also known as drug costs are a common health care cost for many people and health care systems. Prescription costs are the costs to the end consumer. Medication costs are influenced by multiple factors such as patents, stakeholder influence, and marketing expenses. A number of countries including Canada, parts of Europe, and Brazil use external reference pricing as a means to compare drug prices and to determine a base price for a particular medication. Other countries use pharmacoeconomics, which looks at the cost/benefit of a product in terms of quality of life, alternative treatments, and cost reduction or avoidance in other parts of the health care system. Structures like the UK's National Institute for Health and Clinical Excellence and to a lesser extent Canada's Common Drug Review evaluate products in this way.

Electronic prescription is the computer-based electronic generation, transmission, and filling of a medical prescription, taking the place of paper and faxed prescriptions. E-prescribing allows a physician, physician assistant, pharmacist, or nurse practitioner to use digital prescription software to electronically transmit a new prescription or renewal authorization to a community or mail-order pharmacy. It outlines the ability to send error-free, accurate, and understandable prescriptions electronically from the healthcare provider to the pharmacy. E-prescribing is meant to reduce the risks associated with traditional prescription script writing. It is also one of the major reasons for the push for electronic medical records. By sharing medical prescription information, e-prescribing seeks to connect the patient's team of healthcare providers to facilitate knowledgeable decision making.

<span class="mw-page-title-main">California Health and Safety Code</span> U.S. state law

The California Health and Safety Code is the codification of general statutory law covering the subject areas of health and safety in the state of California. It is one of the 29 California Codes and was originally signed into law by the Governor of California on April 7, 1939.

KwikMed is an approved online pharmacy in the United States which has been granted regulatory approval to operate and sell medications online. Based in Salt Lake City, Utah, KwikMed's parent company, Phoenix Capital Management, is located in Scottsdale, Arizona. Specifically, KwikMed has been granted regulatory approval to prescribe medications for erectile dysfunction, male pattern hair loss and smoking cessation provided specific operating procedures are followed.

Pharmaceutical fraud involves activities that result in false claims to insurers or programs such as Medicare in the United States or equivalent state programs for financial gain to a pharmaceutical company. There are several different schemes used to defraud the health care system which are particular to the pharmaceutical industry. These include: Good Manufacturing Practice (GMP) Violations, Off Label Marketing, Best Price Fraud, CME Fraud, Medicaid Price Reporting, and Manufactured Compound Drugs. Examples of fraud cases include the GlaxoSmithKline $3 billion settlement, Pfizer $2.3 billion settlement, and Merck $650 million settlement. Damages from fraud can be recovered by use of the False Claims Act, most commonly under the qui tam provisions which rewards an individual for being a "whistleblower", or relator (law).

The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services." Maintaining services and lowering medication costs for patients is consistent with the purpose of the program, which is named for the section authorizing it in the Public Health Service Act (PHSA) It was enacted by Congress as part of a larger bill signed into law by President George H. W. Bush.

<span class="mw-page-title-main">Drug disposal</span> Safe disposal of unused drugs

Drug disposal is the discarding of drugs. Individuals commonly dispose of unused drugs that remain after the end of medical treatment. Health care organizations dispose of drugs on a larger scale for a range of reasons, including having leftover drugs after treating patients and discarding of expired drugs. Failure to properly dispose of drugs creates opportunities for others to take them inappropriately. Inappropriate disposal of drugs can also cause drug pollution.

An unused drug or leftover drug is the medicine which remains after the consumer has quit using it. Individual patients may have leftover medicines at the end of their treatment. Health care organizations may keep larger amounts of drugs as part of providing care to a community, and may have unused drugs for a range of reasons. The unused drugs should be destroyed utterly to eliminate the toxic effects of undisposed drugs on flora and fauna. The improper disposal of unused drugs could be the reason for the contamination of Surface, Ground and Drinking Water. Discharge of unused antibiotics and disinfectants in the sewage system may ruin the aquatic life or contamination of drinking water.

Drug recycling, also referred to as medication redispensing or medication re-use, is the idea that health care organizations or patients with unused drugs can transfer them in a safe and appropriate way to another patient in need. The purpose of such a program is reducing medication waste, thereby saving healthcare costs, enlarging medications’ availability and alleviating the environmental burden of medication.

The distribution of medications has special drug safety and security considerations. Some drugs require cold chain management in their distribution.

<span class="mw-page-title-main">Drug labelling</span>

Drug labelling is also referred to as prescription labelling, is a written, printed or graphic matter upon any drugs or any of its container, or accompanying such a drug. Drug labels seek to identify drug contents and to state specific instructions or warnings for administration, storage and disposal. Since 1800s, legislation has been advocated to stipulate the formats of drug labelling due to the demand for an equitable trading platform, the need of identification of toxins and the awareness of public health. Variations in healthcare system, drug incidents and commercial utilization may attribute to different regional or national drug label requirements. Despite the advancement in drug labelling, medication errors are partly associated with undesirable drug label formatting.

References

  1. "Pharma Companies Turning Meds Into Energy". Archived from the original on 2014-10-26.
  2. "Insuring the Future: Current Trends in Health Coverage and the Effects of Implementing the Affordable Care Act" (PDF). The Commonwealth Fund.
  3. Lohr, Steve (23 September 2014). "To Gather Drug Data, a Health Start-Up Turns to Consumers". The New York Times.
  4. "State Prescription Drug Return, Reuse and Recycling Laws". National Conference of State Legislatures.
  5. "Your unused drugs can benefit your facility, those in need". Long-Term Living Magazine.
  6. "SIRUM Presentation at Fast Forward". YouTube . Archived from the original on 2021-12-20.
  7. "State Prescription Drug Return, Reuse and Recycling Laws". National Conference of State Legislature.
  8. "Code of Federal Regulations Title 21". U.S. Food and Drug Administration.